Archive: 18/07/2017
Generic medicines hit Novartis profits
Swiss drugmaker Novartis on Tuesday posted a drop in first half profits amid fierce competition for generic medicines and pricing pressures but said it was set to reach annual targets.
Jul 18, 2017
27 Phase III and 8 Phase II Alzheimer's drugs on track to launch in next five years
Twenty-seven Alzheimer's drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years, according to a revised Alzheimer's pipeline analysis presented today at the Alzheimer's ...
Jul 18, 2017